GIANNI, CATERINA
GIANNI, CATERINA
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Dottorandi
Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer
2025 Conteduca, V.; Scarpi, E.; Rossi, A.; Ferroni, F.; Gurioli, G.; Bleve, S.; Gianni, C.; Schepisi, G.; Brighi, N.; Lolli, C.; Cursano, M. C.; Virga, A.; Casadei, C.; Altavilla, A.; Farolfi, A.; Ulivi, P.; Barone, D.; Matteucci, F.; De Giorgi, U.
Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis
2025 Pontolillo, L.; Davis, A. A.; Gerratana, L.; Medford, A. J.; Wang, J.; Nicolo', E.; Clifton, K.; Velimirovic, M.; Warrior, S.; Podany, E.; Andreopoulou, E.; Serafini, M. S.; Munoz-Arcos, L.; Molteni, E.; Lipsyc-Sharf, M.; Gianni, C.; Bayou, N.; Dai, C. S.; Giannarelli, D.; Bria, E.; Ma, C. X.; Bardia, A.; Reduzzi, C.; Cristofanilli, M.
Circulating tumor DNA detection of local recurrence in a patient with early stage triple-negative breast cancer
2025 Alkassis, S.; Suresh, Y.; Lipsyc-Sharf, M.; Zhang, S.; Gianni, C.; Medford, A.; Bardia, A.; Ashouri, S.; Kapoor, N.
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants
2025 Palleschi, M.; Virga, A.; Scarpi, E.; Fonzi, E.; Musolino, A.; Merloni, F.; Sarti, S.; Danesi, R.; Ravegnani, M.; Casadei, C.; Sirico, M.; Gianni, C.; Maltoni, R.; Bravaccini, S.; Calistri, D.; Arcangeli, V.; Zampiga, V.; Cangini, I.; Bandini, E.; Mannozzi, F.; Falcini, F.; Martinelli, G.; De Giorgi, U.; Ulivi, P.; Tedaldi, G.
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study
2025 Farolfi, A; Gianni, C; Palleschi, M; Casadei, C; Montanari, D; Miserocchi, G; Ibarburu, Gh; Gentili, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Sirico, M; Maltoni, R; Cecconetto, L; Sarti, S; Musolino, A
Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study
2025 Gianni, C.; Scarpi, E.; Bravaccini, S.; Pirini, F.; Vanni, S.; Dall'Agata, M.; Cortesi, M.; Fanini, F.; Cavalieri, S.; Mercatali, L.; Ulivi, P.; Poini, A.; Giovanardi, C. M.; Rocca, A.; Fedeli, A.
Mapping breast cancer therapy with circulating tumor cells: The expert perspective
2025 Gerratana, L.; Gianni, C.; Nicolo, E.; Pontolillo, L.; Bidard, F. -C.; Reduzzi, C.; Cristofanilli, M.
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer
2025 Nehme, J.; Maassen, S.; Bravaccini, S.; Zanoni, M.; Gianni, C.; De Giorgi, U.; Soto-Gamez, A.; Altulea, A.; Gheorghe, T.; Wang, B.; Demaria, M.
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions
2025 Sarti, S.; Viansone, A. A.; Serra, O.; Casadei, C.; Cecconetto, L.; Di Menna, G.; Farolfi, A.; Gianni, C.; Mariotti, M.; Merloni, F.; Palleschi, M.; Sirico, M.; Zoppoli, G.; Musolino, A.
Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer
2025 Bayou, N.; Henretta, S.; Munoz-Arcos, L.; Molteni, E.; Gianni, C.; Serafini, M. S.; Nicolo, E.; Pontolillo, L.; Pasto, B.; Gaudio, H. A.; Manai, M.; Afghan, M. M. K.; Manohar, J.; Elemento, O.; Andreopoulou, E.; Cristofanilli, M.; Reduzzi, C.
Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates
2025 Nicolo, E.; Gianni, C.; Tarantino, P.
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS
2025 Farolfi, A; Petracci, E; Casadei, C; Paoletti, E; Gianni, C; Palleschi, M; Sabbioni, S; Montanari, D; Miserocchi, G; Gentili, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Carlini, A; Sirico, M; Maltoni, R; Serra, O; Cecconetto, L; Sarti, S; Muscolino, A
Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all?
2024 Gianni, C.; Nicolo, E.; Cristofanilli, M.
Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer
2024 Nicolo, E.; Gianni, C.; Pontolillo, L.; Serafini, M. S.; Munoz-Arcos, L. S.; Andreopoulou, E.; Curigliano, G.; Reduzzi, C.; Cristofanilli, M.
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404)
2024 Sirico, M.; Jacobs, F.; Molinelli, C.; Nader-Marta, G.; Debien, V.; Dewhurst, H. F.; Pallesch, M.; Merloni, F.; Gianni, C.; De Giorgi, U.; De Azambuja, E.
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900))
2024 Sirico, M.; Virga, A.; Conte, B.; Urbini, M.; Ulivi, P.; Gianni, C.; Merloni, F.; Palleschi, M.; Gasperoni, M.; Curcio, A.; Saha, D.; Buono, G.; Munoz, M.; De Giorgi, U.; Schettini, F.
Impact of circulating tumor DNA (ctDNA) surveillance on clinical care for patients with stage I-III breast cancer: Findings from a multi-institutional study
2024 Lipsyc-Sharf, M.; Fitzsimmons, K.; Medford, A. J.; Podany, E. L.; Sedrak, M. S.; Mcandrew, N. P.; Callahan, R. D.; Kapoor, N. S.; Master, A. K.; Rivero-Hinojosa, S.; Fielder, J.; Rodriguez, A. A.; Liu, M. C.; Knape, J.; Donahue, J.; Gianni, C.; Davis, A. A.; Cristofanilli, M.; Bardia, A.
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives
2024 Merloni, F.; Palleschi, M.; Gianni, C.; Sirico, M.; Serra, R.; Casadei, C.; Sarti, S.; Cecconetto, L.; Di Menna, G.; Mariotti, M.; Maltoni, R.; Montanari, D.; Romeo, A.; De Giorgi, U.
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine
2024 Nicolo, E.; Gianni, C.; Curigliano, G.; Reduzzi, C.; Cristofanilli, M.
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study
2024 Canino, F.; Barbolini, M.; De Giorgi, U.; Fontana, T.; Gaspari, V.; Gianni, C.; Gianni, L.; Maestri, A.; Minichillo, S.; Moscetti, L.; Mura, A.; Nicoletti, S. V. L.; Omarini, C.; Pagani, R.; Sarti, S.; Toss, A.; Zamagni, C.; Cuoghi Costantini, R.; Caggia, F.; Antonelli, G.; Baglio, F.; Belluzzi, L.; Martinelli, G.; Natalizio, S.; Ponzoni, O.; Dominici, M.; Piacentini, F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer | Conteduca, V.; Scarpi, E.; Rossi, A.; Ferroni, F.; Gurioli, G.; Bleve, S.; Gianni, C.; Schepisi, ...G.; Brighi, N.; Lolli, C.; Cursano, M. C.; Virga, A.; Casadei, C.; Altavilla, A.; Farolfi, A.; Ulivi, P.; Barone, D.; Matteucci, F.; De Giorgi, U. | 2025-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | oyaf107_suppl_supplementary_tables_1-7_figures_1.docx; oyaf107.pdf |
| Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysis | Pontolillo, L.; Davis, A. A.; Gerratana, L.; Medford, A. J.; Wang, J.; Nicolo', E.; Clifton, K.; ...Velimirovic, M.; Warrior, S.; Podany, E.; Andreopoulou, E.; Serafini, M. S.; Munoz-Arcos, L.; Molteni, E.; Lipsyc-Sharf, M.; Gianni, C.; Bayou, N.; Dai, C. S.; Giannarelli, D.; Bria, E.; Ma, C. X.; Bardia, A.; Reduzzi, C.; Cristofanilli, M. | 2025-01-01 | NPJ BREAST CANCER | - | 1.01 Articolo in rivista | 41523_2025_Article_802.pdf; 41523_2025_802_MOESM1_ESM.pdf |
| Circulating tumor DNA detection of local recurrence in a patient with early stage triple-negative breast cancer | Alkassis, S.; Suresh, Y.; Lipsyc-Sharf, M.; Zhang, S.; Gianni, C.; Medford, A.; Bardia, A.; Ashou...ri, S.; Kapoor, N. | 2025-01-01 | BREAST CANCER RESEARCH AND TREATMENT | - | 1.06 Abstract in rivista | - |
| Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants | Palleschi, M.; Virga, A.; Scarpi, E.; Fonzi, E.; Musolino, A.; Merloni, F.; Sarti, S.; Danesi, R....; Ravegnani, M.; Casadei, C.; Sirico, M.; Gianni, C.; Maltoni, R.; Bravaccini, S.; Calistri, D.; Arcangeli, V.; Zampiga, V.; Cangini, I.; Bandini, E.; Mannozzi, F.; Falcini, F.; Martinelli, G.; De Giorgi, U.; Ulivi, P.; Tedaldi, G. | 2025-01-01 | THE ONCOLOGIST | - | 1.01 Articolo in rivista | The Oncologist.pdf; file supplementari.zip |
| Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study | Farolfi, A; Gianni, C; Palleschi, M; Casadei, C; Montanari, D; Miserocchi, G; Ibarburu, Gh; Genti...li, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Sirico, M; Maltoni, R; Cecconetto, L; Sarti, S; Musolino, A | 2025-01-01 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - | 1.01 Articolo in rivista | - |
| Investigating biochemical markers of Acupuncture's effectiveness in managing climacteric syndrome in breast cancer patients: the FLAIR study | Gianni, C.; Scarpi, E.; Bravaccini, S.; Pirini, F.; Vanni, S.; Dall'Agata, M.; Cortesi, M.; Fanin...i, F.; Cavalieri, S.; Mercatali, L.; Ulivi, P.; Poini, A.; Giovanardi, C. M.; Rocca, A.; Fedeli, A. | 2025-01-01 | SUPPORTIVE CARE IN CANCER | - | 1.01 Articolo in rivista | - |
| Mapping breast cancer therapy with circulating tumor cells: The expert perspective | Gerratana, L.; Gianni, C.; Nicolo, E.; Pontolillo, L.; Bidard, F. -C.; Reduzzi, C.; Cristofanilli..., M. | 2025-01-01 | BREAST | - | 1.01 Articolo in rivista | The Breast 2025.pdf |
| Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer | Nehme, J.; Maassen, S.; Bravaccini, S.; Zanoni, M.; Gianni, C.; De Giorgi, U.; Soto-Gamez, A.; Al...tulea, A.; Gheorghe, T.; Wang, B.; Demaria, M. | 2025-01-01 | EMBO JOURNAL | - | 1.01 Articolo in rivista | - |
| Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions | Sarti, S.; Viansone, A. A.; Serra, O.; Casadei, C.; Cecconetto, L.; Di Menna, G.; Farolfi, A.; Gi...anni, C.; Mariotti, M.; Merloni, F.; Palleschi, M.; Sirico, M.; Zoppoli, G.; Musolino, A. | 2025-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-17-03597.pdf |
| Quantitative HER2 profiling on circulating tumor cells using an EpCAM-independent platform in metastatic breast cancer | Bayou, N.; Henretta, S.; Munoz-Arcos, L.; Molteni, E.; Gianni, C.; Serafini, M. S.; Nicolo, E.; P...ontolillo, L.; Pasto, B.; Gaudio, H. A.; Manai, M.; Afghan, M. M. K.; Manohar, J.; Elemento, O.; Andreopoulou, E.; Cristofanilli, M.; Reduzzi, C. | 2025-01-01 | CANCER CELL INTERNATIONAL | - | 1.01 Articolo in rivista | 12935_2025_Article_4036.pdf; 12935_2025_4036_MOESM1_ESM.docx |
| Redefining Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer in the Era of Novel Antibody-Drug Conjugates | Nicolo, E.; Gianni, C.; Tarantino, P. | 2025-01-01 | JCO ONCOLOGY PRACTICE | - | 1.01 Articolo in rivista | - |
| ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS | Farolfi, A; Petracci, E; Casadei, C; Paoletti, E; Gianni, C; Palleschi, M; Sabbioni, S; Montanari..., D; Miserocchi, G; Gentili, N; Mariotti, M; Testoni, S; Di Menna, G; Rusconi, F; Andalò, A; Merloni, F; Carlini, A; Sirico, M; Maltoni, R; Serra, O; Cecconetto, L; Sarti, S; Muscolino, A | 2025-01-01 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | - | 1.06 Abstract in rivista | - |
| Adjuvant CDK4/6 inhibitors in hormone receptor-positive early breast cancer: one fits all? | Gianni, C.; Nicolo, E.; Cristofanilli, M. | 2024-01-01 | TRANSLATIONAL BREAST CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer | Nicolo, E.; Gianni, C.; Pontolillo, L.; Serafini, M. S.; Munoz-Arcos, L. S.; Andreopoulou, E.; Cu...rigliano, G.; Reduzzi, C.; Cristofanilli, M. | 2024-01-01 | TRANSLATIONAL BREAST CANCER RESEARCH | - | 1.01 Articolo in rivista | 85637-PB5-9286-R2.pdf |
| Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) | Sirico, M.; Jacobs, F.; Molinelli, C.; Nader-Marta, G.; Debien, V.; Dewhurst, H. F.; Pallesch, M....; Merloni, F.; Gianni, C.; De Giorgi, U.; De Azambuja, E. | 2024-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) | Sirico, M.; Virga, A.; Conte, B.; Urbini, M.; Ulivi, P.; Gianni, C.; Merloni, F.; Palleschi, M.; ...Gasperoni, M.; Curcio, A.; Saha, D.; Buono, G.; Munoz, M.; De Giorgi, U.; Schettini, F. | 2024-01-01 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Impact of circulating tumor DNA (ctDNA) surveillance on clinical care for patients with stage I-III breast cancer: Findings from a multi-institutional study | Lipsyc-Sharf, M.; Fitzsimmons, K.; Medford, A. J.; Podany, E. L.; Sedrak, M. S.; Mcandrew, N. P.;... Callahan, R. D.; Kapoor, N. S.; Master, A. K.; Rivero-Hinojosa, S.; Fielder, J.; Rodriguez, A. A.; Liu, M. C.; Knape, J.; Donahue, J.; Gianni, C.; Davis, A. A.; Cristofanilli, M.; Bardia, A. | 2024-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.06 Abstract in rivista | - |
| Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives | Merloni, F.; Palleschi, M.; Gianni, C.; Sirico, M.; Serra, R.; Casadei, C.; Sarti, S.; Cecconetto..., L.; Di Menna, G.; Mariotti, M.; Maltoni, R.; Montanari, D.; Romeo, A.; De Giorgi, U. | 2024-01-01 | CLINICAL & EXPERIMENTAL METASTASIS | - | 1.01 Articolo in rivista | - |
| Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine | Nicolo, E.; Gianni, C.; Curigliano, G.; Reduzzi, C.; Cristofanilli, M. | 2024-01-01 | CURRENT OPINION IN ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study | Canino, F.; Barbolini, M.; De Giorgi, U.; Fontana, T.; Gaspari, V.; Gianni, C.; Gianni, L.; Maest...ri, A.; Minichillo, S.; Moscetti, L.; Mura, A.; Nicoletti, S. V. L.; Omarini, C.; Pagani, R.; Sarti, S.; Toss, A.; Zamagni, C.; Cuoghi Costantini, R.; Caggia, F.; Antonelli, G.; Baglio, F.; Belluzzi, L.; Martinelli, G.; Natalizio, S.; Ponzoni, O.; Dominici, M.; Piacentini, F. | 2024-01-01 | BMC CANCER | - | 1.01 Articolo in rivista | - |